Finch Therapeutics Group, Inc. (FNCH)

Finch Therapeutics Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.04	25.12	71.04	133.48	99.71	42.19
Cash & Short-Term Investments	16.04	25.12	71.04	133.48	99.71	42.19
Cash Growth	-52.91%	-64.63%	-46.78%	33.87%	136.36%	-
Accounts Receivable	-	-	0.14	0.49	1.1	1.75
Other Receivables	-	-	-	-	-	3
Receivables	-	-	0.14	0.49	1.1	4.75
Prepaid Expenses	1.24	0.72	3.37	8.58	5.36	1.69
Total Current Assets	17.28	25.85	74.55	142.55	106.16	48.63
Property, Plant & Equipment	25.95	27.18	48.69	24.69	7	3.78
Goodwill	-	-	-	18.06	18.06	18.06
Long-Term Deferred Charges	-	-	32.9	32.9	33.91	32.9
Other Long-Term Assets	2.35	2.35	6.8	7.17	0.2	0.21
Total Assets	45.58	55.37	162.94	225.37	165.34	103.57
Accounts Payable	0.03	0.14	1.1	3.74	2.62	0.66
Accrued Expenses	2.34	1.54	9.09	9.93	5.23	3.96
Current Portion of Leases	2.09	1.72	3.43	1.13	-	-
Current Unearned Revenue	-	-	-	-	3.37	2.38
Other Current Liabilities	-	0.68	1.07	-	0.27	0.33
Total Current Liabilities	4.46	4.08	14.69	14.79	11.49	7.33
Long-Term Debt	-	-	14.65	-	1.81	-
Long-Term Leases	26.9	28.4	34.26	4.89	-	-
Long-Term Unearned Revenue	-	-	-	-	10.26	8.29
Long-Term Deferred Tax Liabilities	-	-	3.46	3.46	3.46	3.46
Other Long-Term Liabilities	-	-	0.17	-	0.99	0.88
Total Liabilities	31.36	32.49	67.23	23.15	28	19.95
Common Stock	0	0	0	0.05	0.01	0.11
Additional Paid-In Capital	373.32	373.28	371.35	363.17	7.11	3.85
Retained Earnings	-359.11	-350.4	-275.64	-161	-102.84	-63.49
Total Common Equity	14.22	22.89	95.71	202.22	-95.72	-59.54
Shareholders' Equity	14.22	22.89	95.71	202.22	137.34	83.62
Total Liabilities & Equity	45.58	55.37	162.94	225.37	165.34	103.57
Total Debt	28.99	30.13	52.34	6.02	1.81	-
Net Cash (Debt)	-12.95	-5	18.7	127.46	97.9	42.19
Net Cash Growth	-	-	-85.33%	30.19%	132.07%	-
Net Cash Per Share	-8.07	-3.12	11.76	97.54	360.60	173.47
Filing Date Shares Outstanding	1.61	1.61	1.6	1.58	0.28	0.26
Total Common Shares Outstanding	1.61	1.61	1.6	1.58	0.28	0.26
Working Capital	12.82	21.76	59.86	127.76	94.68	41.3
Book Value Per Share	8.85	14.25	59.75	127.69	-342.18	-229.61
Tangible Book Value	14.22	22.89	95.71	184.17	-113.78	-77.59
Tangible Book Value Per Share	8.85	14.25	59.75	116.29	-406.73	-299.25
Machinery	0.9	0.87	6.05	4.76	3.11	2.29
Construction In Progress	-	-	0.32	0.33	2.64	-
Leasehold Improvements	-	-	13.97	13.89	2.14	2.75

Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.